200
Views
2
CrossRef citations to date
0
Altmetric
Clinical Research

Efficiency of 123I-ioflupane SPECT as the marker of basal ganglia damage in acute methanol poisoning: 6-year prospective study

, , , , , , , , , , , , , & show all
Pages 235-245 | Received 19 May 2020, Accepted 15 Jul 2020, Published online: 07 Aug 2020

References

  • Blug M, Leker J, Plass L, et al. Methanol generation economics. In: Bertau M, Offermanns H, Plass L, Schmidt F, Wernicke HJ, editors. Methanol: the basic chemical and energy feedstock of the future. Asinger’s vision today. Berlin, Heidelberg: Springer; 2014. p. 603–618.
  • Kemsley J. Methanol's allure. Chem Eng News. 2007;85(49):55–59.
  • Olah GA. Beyond oil and gas: the methanol economy. Angew Chem Int Ed Engl. 2005;44(18):2636–2639.
  • Choi JH, Lee SK, Gil YE, et al. Neurological complications resulting from non-oral occupational methanol poisoning. J Korean Med Sci. 2017;32(2):371–376.
  • Ryu J, Lim K, Ryu D, et al. Two cases of methyl alcohol intoxication by sub-chronic inhalation and dermal exposure during aluminum CNC cutting in a small-sized subcontracted factory. Aoem. 2016;28:65.
  • Soysal D, Yersal Kabayegit O, Yilmaz S, et al. Transdermal methanol intoxication: a case report. Acta Anaesthesiol Scand. 2007;51(6):779–780.
  • Zhang G, Grews K, Wiseman H, et al. Application to include fomepizole on the WHO model list of essential medicines. 2015 (3.8.2015). http://www.who.int/selection_medicines/committees/expert/19/applications/Fomepizole_4_2_AC_Ad.pdf.
  • Gummin DD, Mowry JB, Spyker DA, et al. 2018 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 36th Annual Report. Clin Toxicol (Phila). 2019;57(12):1220–1413.
  • Hovda KE, Hunderi OH, Tafjord AB, et al. Methanol outbreak in Norway 2002–2004: epidemiology, clinical features and prognostic signs. J Intern Med. 2005;258(2):181–190.
  • Paasma R, Hovda KE, Tikkerberi A, et al. Methanol mass poisoning in Estonia: outbreak in 154 patients. Clin Toxicol (Phila). 2007;45(2):152–157.
  • Zakharov S, Pelclova D, Urban P, et al. Czech mass methanol outbreak 2012: epidemiology, challenges and clinical features. Clin Toxicol. 2014;52(10):1013–1024.
  • Blanco M, Casado R, Vázquez F, et al. CT and MR imaging findings in methanol intoxication. Am J Neuroradiol. 2006;27(2):452–454.
  • Vaneckova M, Zakharov S, Klempir J, et al. Imaging findings after methanol intoxication (cohort of 46 patients). Neuro Endocrinol Lett. 2015;36:737–744.
  • Zakharov S, Kotikova K, Vaneckova M, et al. Acute methanol poisoning: prevalence and predisposing factors of haemorrhagic and non-haemorrhagic brain lesions. Basic Clin Pharmacol Toxicol. 2016;119(2):228–238.
  • Anderson CA, Rubinstein D, Filley CM, et al. MR enhancing brain lesions in methanol intoxication. J Comput Assist Tomogr. 1997;21(5):834–836.
  • Kuteifan K, Oesterlé H, Tajahmady T, et al. Necrosis and haemorrhage of the putamen in methanol poisoning shown on MRI. Neuroradiology. 1998;40(3):158–160.
  • Chen JC, Schneiderman JF, Wortzman G. Methanol poisoning: bilateral putaminal and cerebellar cortical lesions on CT and MR. J Comput Assist Tomogr. 1991;15(3):522–524.
  • Halavaara J, Valanne L, Setala K. Neuroimaging supports the clinical diagnosis of methanol poisoning. Neuroradiology. 2002;44(11):924–928.
  • Sefidbakht S, Rasekhi AR, Kamali K, et al. Methanol poisoning: acute MR and CT findings in nine patients. Neuroradiology. 2007;49(5):427–435.
  • Vaneckova M, Zakharov S, Klempir J, et al. Methanol intoxication on magnetic resonance imaging. Cesk Slov Neurol N. 2014;77/110(2):235–239.
  • Anderson TJ, Shuaib A, Becker WJ. Neurologic sequelae of methanol poisoning. Can Med Assoc J. 1987;136(11):1177–1179.
  • Bezdicek O, Michalec J, Vaneckova M, et al. Cognitive sequelae of methanol poisoning involve executive dysfunction and memory impairment in cross-sectional and long-term perspective. Alcohol. 2017;59:27–35.
  • Galvez-Ruiz A, Elkhamary SM, Asghar N, et al. Visual and neurologic sequelae of methanol poisoning in Saudi Arabia. Saudi Med J. 2015;36(5):568–574.
  • LeWitt PA, Martin SD. Dystonia and hypokinesis with putaminal necrosis after methanol intoxication. Clin Neuropharmacol. 1988;11(2):161–167.
  • Ley CO, Gali FG. Parkinsonian syndrome after methanol intoxication. Eur Neurol. 1983;22(6):405–409.
  • Reddy NJ, Sudini M, Lewis LD. Delayed neurological sequelae from ethylene glycol, diethylene glycol and methanol poisonings. Clin Toxicol (Phila). 2010;48(10):967–973.
  • Chiò A, Herrero Hernandez E, Mora G, et al. Motor neuron disease and optic neuropathy after acute exposure to a methanol-containing solvent mixture. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(3):188–191.
  • McLean DR, Jacobs H, Mielke BW. Methanol poisoning: a clinical and pathological study. Ann Neurol. 1980;8(2):161–167.
  • Santos-Garcia D, Lopez-Dequidt IA, Exposito-Ruiz I, et al. Anton’s syndrome due to occipital necrosis after methanol poisoning]. Rev Neurol. 2015;60(2):90. [ [Article in Spanish].
  • Nurieva O, Diblik P, Kuthan P, et al. Progressive chronic retinal axonal loss following acute methanol-induced optic neuropathy: four-year prospective cohort study. Am J Ophthalmol. 2018;191:100–115.
  • Rulisek J, Waldauf P, Belohlavek J, et al. Health-related quality of life determinants in survivors of a mass methanol poisoning outbreak: six-year prospective cohort study. Clin Toxicol. 2020;8:1–11.
  • Hlusicka J, Mana J, Vaneckova M, et al. MRI-based brain volumetry and retinal optical coherence tomography as the biomarkers of outcome in acute methanol poisoning. NeuroToxicology. 2020;80:12–19.
  • Blanco M, Casado R, Vazquez F, et al. CT and MR imaging findings in methanol intoxication. Am J Neuroradiol. 2006;27(2):452–454.
  • Zakharov S, Kotikova K, Nurieva O, et al. Leukotriene-mediated neuroinflammation, toxic brain damage, and neurodegeneration in acute methanol poisoning. Clin Toxicol. 2017;55(4):249–259.
  • Viola A, Stvrtina S, Bauer V, et al. Morphologic and clinical sequelae of focal ischemic lesions. Cesk Patol. 2000;36(4):140–145.
  • Luo X, Mao Q, Shi J, et al. Putamen gray matter volumes in neuropsychiatric and neurodegenerative disorders. World J Psychiatry Ment Health Res. 2019;3(1): 1020.
  • Haber SN. Corticostriatal circuitry. Dialogues Ckin Neurosci. 2016;18(1):7–21.
  • Darcourt J, Booij J, Tatsch K, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37(2):443–450.
  • Doe de Maindreville A, Bakchine S, Papathanassiou D, et al. Evidence of presynaptic dopaminergic dysfunction in acute methanol intoxication. Rev Neurol (Paris). 2017;173(6):420–422.
  • Airas L, Paavilainen T, Marttila RJ, et al. Methanol intoxication-induced nigrostriatal dysfunction detected using 6-[18F]fluoro-L-dopa PET. Neurotoxicology. 2008;29(4):671–674.
  • Barceloux DG, Bond GR, Krenzelok EP, American Academy of Clinical Toxicology Ad Hoc Committee on the Treatment Guidelines for Methanol Poisoning, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002;40(4):415–446.
  • Paasma R, Hovda KE, Hassanian-Moghaddam H, et al. Risk factors related to poor outcome after methanol poisoning and the relation between outcome and antidotes – a multicenter study. Clin Toxicol. 2012;50(9):823–831.
  • Zakharov S, Pelclova D, Navratil T, et al. Fomepizole versus ethanol in the treatment of acute methanol poisoning: comparison of clinical effectiveness in a mass poisoning outbreak. Clin Toxicol. 2015;53(8):797–806.
  • Zakharov S, Pelclova D, Navratil T, et al. Efficiency of acidemia correction on intermittent versus continuous hemodialysis in acute methanol poisoning. Clin Toxicol. 2017;55(2):123–132.
  • Mana J, Vaneckova M, Klempíř J, et al. Methanol poisoning as an acute toxicological basal ganglia lesion model: evidence from brain volumetry and cognition. Alcohol Clin Exp Re. 2019;43(7):1486–1497.
  • Schmitter D, Roche A, Maréchal B, Alzheimer's Disease Neuroimaging Initiative, et al. An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease. Neuroimage Clin. 2015;7(1):7–17.
  • Mäkinen E, Joutsa J, Johansson J, et al. Visual versus automated analysis of [I-123]FP-CIT SPECT scans in parkinsonism. J Neural Transm. 2016;123(11):1309–1318.
  • Colloby SJ, McParland S, O'Brien JT, et al. Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias. Brain. 2012;135(Pt 9):2798–2808.
  • Kordower JH, Olanow CW, Dodiya HB, et al. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain. 2013;136(Pt 8):2419–2431.
  • Shankaran S, Niimura K, Muzik O, et al. Selective vulnerability of posterior putamen on positron emission tomography (pet) in perinatal hypoxic-ischemic brain injury. Pediatr Res. 1999;45(4, Part 2 of 2):347A.
  • Okuzumi A, Hatano T, Kamagata K, et al. Neuromelanin or DaT-SPECT: which is the better marker for discriminating advanced Parkinson's disease? Eur J Neurol. 2019;26(11):1408–1416.
  • Jakobson Mo S, Axelsson J, Jonasson L, et al. Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT-a clinical comparison. EJNMMI Res. 2018;8(1):100.
  • Varrone A, Dickson JC, Tossici-Bolt L, et al. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging. 2013;40(2):213–227.
  • Zakharov S, Kurcova I, Navratil T, et al. Is the measurement of serum formate concentration useful in the diagnostics of acute methanol poisoning? A prospective study of 38 patients. Basic Clin Pharmacol Toxicol. 2015;116(5):445–451.
  • Das D, Cherbuin N, Anstey KJ, et al. Lifetime cigarette smoking is associated with striatal volume measures. Addict Biol. 2012;17(4):817–825.
  • Nurieva O, Hubacek JA, Urban P, et al. Clinical and genetic determinants of chronic visual pathway changes after methanol-induced optic neuropathy: four-year follow-up study. Clin Toxicol. 2019;57(6):387–397.
  • Peterová K, Brožová H, Klempíř J, et al. Gait and balance impairment after acute methanol poisoning. Basic Clin Pharmacol Toxicol. 2018;122(1):176–182.
  • Marek K, Seibyl J, Eberly S, For The Parkinson Study Group PRECEPT Investigators, et al. Longitudinal follow-up of SWEDD subjects in the PRECEPT study. Neurology. 2014;82(20):1791–1797.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.